What does Latisse do?
Latisse is FDA-approved to make eyelashes longer, thicker and darker. This treatment is especially beneficial if you have thin, sparse eyelashes. With regular application, Latisse can give you full, glamorous eyelashes.
Latisse is the brand name of a drug formula – bimatoprost – originally used to treat glaucoma, which is sold under the brand name Lumigan. Lumigan is a prescription eyedrop medication. It became apparent that Lumigan eye drops had the effect of lengthening and thickening the eyelashes, so eventually a cosmetic form of the drug was made and sold as Latisse.
In order for Latisse to work, you need to apply it according to the instructions of our cosmetic surgeon Dr. John Lee. After about 2 to 4 months, you should notice a difference in the thickness and length of your eyelashes. You must keep using Latisse regularly for results to last; the results will begin to fade if you stop use of Latisse.
Latisse has been a great way for many of our patients to get more voluminous eyelashes. But it’s important to seek a qualified cosmetic surgeon like Dr. Lee to get a prescription for Latisse. Like any prescription drug, Latisse carries the risks of certain side effects, especially if you are not a good candidate for it or if it is applied incorrectly. Our cosmetic staff will make sure you are informed of all the possible risks of Latisse and that you know how to use it correctly.
For a greater Philadelphia Latisse consultation, please contact John J.W. Lee, MD, FACS.
Categories
- Blepharoplasty (11)
- Blog (99)
- BOTOX (12)
- Brow Lift (6)
- CoolSculpting (8)
- CoolTone (2)
- Cosmetic Surgery (18)
- Dysport (2)
- Eyelid Surgery (6)
- Facelift (7)
- Facial Fillers (12)
- Facial Rejuvenation (4)
- Infini RF Microneedling (2)
- Juvederm (6)
- Kybella (3)
- Laser & IPL (7)
- Laser Hair Removal (2)
- Latisse (1)
- Liquid Facelift (1)
- Medical Skincare (1)
- MedSpa (1)
- Plastic Surgery (12)
- Practice News (1)
- Ptosis (3)
- Rhinoplasty (1)
- Scar revision (1)
- Skin Care (5)
- Skin Care Products (1)
- Uncategorized (7)
Recent Post
Archives
- January 2023 (1)
- December 2022 (1)
- November 2022 (1)
- October 2022 (1)
- September 2022 (1)
- August 2022 (1)
- July 2022 (1)
- June 2022 (1)
- May 2022 (1)
- April 2022 (1)
- March 2022 (1)
- February 2022 (1)
- January 2022 (1)
- December 2021 (1)
- November 2021 (1)
- October 2021 (1)
- September 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- May 2021 (1)
- April 2021 (1)
- March 2021 (1)
- February 2021 (1)
- January 2021 (2)
- November 2020 (1)
- October 2020 (1)
- September 2020 (1)
- August 2020 (9)
- July 2020 (1)
- May 2020 (4)
- April 2020 (3)
- March 2020 (9)
- February 2020 (2)
- January 2020 (2)
- March 2019 (1)
- February 2019 (1)
- January 2019 (1)
- December 2018 (1)
- November 2018 (1)
- October 2018 (1)
- September 2018 (1)
- August 2018 (1)
- July 2018 (1)
- June 2018 (1)
- May 2018 (1)
- April 2018 (1)
- March 2018 (1)
- February 2018 (1)
- January 2018 (1)
- December 2017 (1)
- November 2017 (1)
- October 2017 (1)
- September 2017 (1)
- August 2017 (1)
- July 2017 (1)
- June 2017 (1)
- May 2017 (1)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- January 2017 (1)
- December 2016 (1)
- November 2016 (1)
- October 2016 (1)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
- June 2016 (1)
- May 2016 (1)
- April 2016 (1)
- March 2016 (1)
- February 2016 (2)
- January 2016 (1)
- December 2015 (1)
- November 2015 (1)
- October 2015 (2)
- September 2015 (1)
- August 2015 (1)
- July 2015 (1)
- June 2015 (1)
- May 2015 (1)
- April 2015 (1)
- March 2015 (1)
- February 2015 (1)
- January 2015 (2)
- December 2014 (1)
- August 2014 (3)
- July 2014 (3)
- June 2014 (3)
- May 2014 (3)
- April 2014 (3)
- March 2014 (2)
- February 2014 (2)
- January 2014 (1)
- December 2013 (3)
- November 2013 (3)
- October 2013 (3)
- September 2013 (3)
- August 2013 (3)
- July 2013 (4)
- June 2013 (2)
- May 2013 (3)
- April 2013 (7)
- March 2013 (8)
- June 2012 (1)